Acepodia, Inc. (TPEX:6976)
Taiwan · Delayed Price · Currency is TWD 11.75
-0.20 (-1.67%)
Mar 24, 2026, 1:57 PM CST
Acepodia Market Cap
Acepodia has a market cap or net worth of 6.93 billion as of March 24, 2026. Its market cap has decreased by -48.84% in one year.
Market Cap
6.93B
Enterprise Value
2.09B
Revenue
301.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
11.75
Market Cap Chart
Since August 8, 2023, Acepodia's market cap has decreased from 22.92B to 6.93B, a decrease of -69.78%. That is a compound annual growth rate of -36.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 6.96B | -22.16% |
| Dec 31, 2025 | 8.94B | -10.43% |
| Dec 31, 2024 | 9.98B | -48.47% |
| Dec 29, 2023 | 19.36B | -15.54% |
| Aug 8, 2023 | 22.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gongwin Biopharm Holdings | 8.80B |
| PharmaEngine | 8.36B |
| TaiGen Biopharmaceuticals Holdings | 8.22B |
| Adimmune | 7.65B |
| Mycenax Biotech | 6.56B |
| Savior Lifetec | 6.40B |
| AnnJi Pharmaceutical | 5.92B |
| Sinphar Pharmaceutical | 5.90B |